Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain
Clinical trial NCT05909709 · RECRUITING
Trial details
- NCT number
- NCT05909709
- Sponsor
- Alimorad Farshchian
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-29
- Primary completion
- 2026-10-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.